THE IMPACT OF COVID-19 ON HEMATOLOGY ANALYZERS MARKET

                                      THE IMPACT OF COVID-19 ON HEMATOLOGY ANALYZERS MARKET

The cellular and morphological analysis is an integral part of any hematology laboratory. The hematology analyzers are being used predominantly for cell counts and differential leukocyte analysis, but in addition, these analyzers are capable of reporting many additional parameters and can provide much more information than what they are intended to provide, but unfortunately, due to lack of knowledge and propagation, they are not being optimally utilized to their potential.

Hematology deals with diseases aspects affecting the blood-forming organs and blood, which includes bleeding disorders, clotting problems, and anemia. It also deals with transfusion medicine, which involves performing blood typing, crossmatching for compatibility and managing large amounts of blood products.

The Hematology Analyzer market is primarily being driven by rises in the prevalence of anaemia, increased incidence of blood related diseases and disorders, and the growing importance of blood cell counts in routine diagnostic procedures for patient treatment and monitoring.

Today we are determined to overcome these confinement constraints in order to prevent the spread of this virus. Thus, all of BIOBASE Biotech and all of its teams are committed to ensuring business continuity across all of our services for the benefit of our suppliers, customers and patients. The production of instruments and reagents are maintained as well as the support departments of the company which are also connected in order to stay by your side whatever your requests.